Cadre Holdings Inc (CDRE) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Cadre Holdings inc   (NYSE: CDRE)


Cadre Holdings Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Cadre Holdings Inc's ROI in the third quarter of 2026?
Cadre Holdings inc achieved a return on average invested assets (ROI) of 5.56 % in its third quarter of 2026, this is above CDRE's average return on investment of 5.27%.
Cadre Holdings Inc invested over the 12 months ending in its third quarter of 2026 $740 million

ROI has improved compared to 4.97% in the second quarter of 2026, due to net income growth.

Within the Healthcare sector 144 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 1229 to 1532.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM 14.22 % 19.55 % 33.61 % 29.55 % 39.3 %
Y / Y Net Income Change TTM -9.42 % -5.34 % 42.42 % 165.29 % 1141.67 %
Investment (TTM) in Millions 745 730 819 666 686
Return On Investment (TTM) 5.56 % 4.97 % 5.06 % 6.55 % 7.01 %
CDRE's Overall Ranking # 1532 # 1229 # 886 # 989 #
Seq. Investment Change TTM 2.02 % -0.47 % 8.02 % 4.13 % 6.78 %
Seq. Net Income Change TTM 13.99 % -2.18 % -16.48 % -2.74 % 19.12 %
Net Income (TTM) in Millions 41 36 37 44 45

CDRE Company Profile >> Back to CDRE Roi Comparisons >> See Annual CDRE Return On Investment



Return On Investment CDRE's Ranking
Within: No.
Industry # 43
Sector # 145
Overall # 1532

Return On Investment Statistics
High Average Low
11.72 %
5.27 %
-9.45 %
(Dec 31 2023)   (Sep 30 2021)







Financial Statements
Cadre Holdings Inc's III. Quarter Investments $ 745 Millions CDRE's Balance sheet
Cadre Holdings Inc's III. Quarter Income $ 16 Millions Quarterly CDRE's Income Statement
CDRE's Income by Division See CDRE's Income by Division


CDRE Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 666 559 336 313 236
Y / Y Investment Growth 19.15 % 66.26 % 7.33 % 32.71 % -
Net Income in Millions 44 36 39 6 13
Y / Y Net Income Growth 22.16 % -6.49 % 563.93 % -54.03 % -
Annual Return On Investment 6.63 % 6.47 % 11.5 % 1.86 % 5.37 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 6.63 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CDRE's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CDRE's Competitors
Subscribers only: Roi for Cadre Holdings Inc's Suppliers
Subscribers only: Return On Investment for CDRE's Customers

Other Ratios
CDRE's Roa CDRE's Inventory Turnover Ratio CDRE's Growth Rates CDRE's Dividend Statistics
CDRE's Profitability Ratios CDRE's Asset Turnover Ratio CDRE's Dividend Growth
CDRE's Roe CDRE's Valuation Ratios CDRE's Financial Strength Ratios CDRE's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Amgen Inc   13.64 %
Carlisle Companies Incorporated  13.64 %
Bristol myers Squibb Company  13.59 %
3m Company  13.24 %
Alpha Pro Tech Ltd   13.18 %
Beone Medicines Ltd   13.17 %
Regeneron Pharmaceuticals Inc   13.00 %
Abbvie Inc   12.87 %
Lantheus Holdings Inc   11.96 %
Msa Safety Inc  11.78 %
Inspire Medical Systems inc   11.63 %
Transmedics Group Inc   11.55 %
Bioventus Inc   11.26 %
Tenet Healthcare Corp  10.91 %
Bio rad Laboratories Inc   10.59 %
Lemaitre Vascular Inc   10.56 %
Johnson and Johnson  10.53 %
Encompass Health Corporation  10.41 %
Ani Pharmaceuticals Inc  9.61 %
Tactile Systems Technology Inc   9.27 %
Boston Scientific Corporation  9.14 %
Brightspring Health Services Inc   9.01 %
Stryker Corp  8.63 %
Pediatrix Medical Group Inc   8.37 %
Penumbra Inc  8.28 %
Medinotec Inc   8.12 %
Pacific Health Care Organization Inc  8.09 %
Quest Diagnostics Inc  8.01 %
Ge Healthcare Technologies Inc   7.60 %
Incyte Corporation  6.81 %

Date modified: 2026-11-06T13:05:41+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.